Methane is becoming a major candidate for a prominent carbon feedstock in the future, and the bioconversion of methane into valuable products has drawn increasing attention. To facilitate the use of methanotrophic organisms as industrial strains and accelerate our ability to metabolically engineer methanotrophs, simple and rapid genetic tools are needed. Electroporation is one such enabling tool, but to date it has not been successful in a group of methanotrophs of interest for the production of chemicals and fuels, the gammaproteobacterial (type I) methanotrophs. In this study, we developed electroporation techniques with a high transformation efficiency for three different type I methanotrophs: Methylomicrobium buryatense 5GB1C, Methylomonas sp. strain LW13, and Methylobacter tundripaludum 21/22. We further developed this technique in M. buryatense, a haloalkaliphilic aerobic methanotroph that demonstrates robust growth with a high carbon conversion efficiency and is well suited for industrial use for the bioconversion of methane. On the basis of the high transformation efficiency of M. buryatense, gene knockouts or integration of a foreign fragment into the chromosome can be easily achieved by direct electroporation of PCR-generated deletion or integration constructs. Moreover, site-specific recombination (FLP-FRT [FLP recombination target] recombination) and sacB counterselection systems were employed to perform marker-free manipulation, and two new antibiotics, zeocin and hygromycin, were validated to be antibiotic markers in this strain. Together, these tools facilitate the rapid genetic manipulation of M. buryatense and other type I methanotrophs, promoting the ability to perform fundamental research and industrial process development with these strains.
Methane, the principal component of natural gas and biogas, is a cheap, abundant, and renewable energy and carbon source. However, methane is also the second most prevalent greenhouse gas (1). Therefore, technologies to efficiently convert methane to chemicals or fuels can bring new sustainable solutions to a number of industries with large environmental footprints. Methane-oxidizing bacteria (methanotrophs) are able to use methane as their sole source of carbon and energy and thus are promising systems for methane-based bioconversion (2, 3). The bioconversion of methane to industrial products (single-cell proteins, biopolymers, lipids, etc.) using aerobic methanotrophs has been studied for approximately 50 years but has had little enduring success (4). Current biological engineering and systems biology approaches provide new opportunities for metabolic engineering of methanotrophs. However, to be an industrial workhorse like Escherichia coli, an industrial methanotroph needs to have a high growth rate, and efficient genetic tools for its manipulation and a fundamental knowledge base are needed.Many methanotrophs have been isolated and characterized since the classic study of Whittenbury et al. (5). Aerobic methanotrophs are found in two major groups, the...